Stock CGC CANOPY GROWTH CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Canopy Growth Corp Stock Toronto S.E.

Equities

CGC

CA1380351009

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for Canopy Growth Corp
05-16 Pot stocks rise as US unveils proposal to ease restrictions on marijuana RE
05-16 US Government Reclassifies Marijuana to Less-Restrictive Category MT
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 321M 235M Sales 2025 * 303M 222M Capitalization 1.04B 760M
Net income 2024 * -491M -360M Net income 2025 * -121M -88.72M EV / Sales 2024 * 4.56 x
Net Debt 2024 * 427M 313M Net Debt 2025 * 403M 295M EV / Sales 2025 * 4.76 x
P/E ratio 2024 *
-2.36 x
P/E ratio 2025 *
-11.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.85%
More Fundamentals * Assessed data

Latest news about Canopy Growth Corp

Pot stocks rise as US unveils proposal to ease restrictions on marijuana RE
US Government Reclassifies Marijuana to Less-Restrictive Category MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification DJ
Justice Department Set to Post Cannabis Reclassification Plans MT
Investors wary of US cannabis ETFs despite recent rally RE
Canopy USA Exercises Options to Acquire Wana, Jetty MT
Canopy Growth Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty MT
Canopy Growth Brief: Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty MT
Canopy Growth Corporation exercised its option to acquire Wana Brands for $300 million. CI
Canopy Growth Corporation exercised its option to acquire 75% interest in Jetty Extracts. CI
Canopy Growth to Get $50 Million in Proceeds From Debt Accord MT
Canopy Growth Secures US$50 Million in Financing MT
Canopy Growth Brief: C$27.5 Millon of Debt Extended from 2025 to 2029 MT
Canopy Growth Brief: Announcing Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds MT
Canopy Growth Corporation announced that it expects to receive CAD 27.5 million in funding CI
More news

Latest transcript on Canopy Growth Corp

Logo Canopy Growth Corp
Canopy Growth Corporation, Q3 2024 Earnings Call, Feb 09, 2024
More transcripts

Analyst Recommendations on Canopy Growth Corp

Investors wary of US cannabis ETFs despite recent rally RE
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Starbucks, Super Micro Computer to Decline MT
Canopy Growth Slides After Constellation Directors Leave, Share Conversion DJ
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
TSX futures slip on hawkish Fed remarks, lower metal prices RE
More recommendations

Press releases Canopy Growth Corp

Canopy Growth to Report Fourth Quarter and Fiscal Year 2024 Financial Results on May 30, 2024 AQ
Canopy Growth Confirms Canopy USA's Exercise of Options to Acquire Wana and Jetty AQ
Canopy Growth Announces Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds AQ
Canadian Investment Regulatory Organization Trade Resumption - WEED AQ
Canadian Investment Regulatory Organization Trading Halt - WEED AQ
More press releases

News in other languages on Canopy Growth Corp

MÄRKTE USA/Leichter - Dow & Co mit Strohfeuer nach Fed-Kommentaren
MÄRKTE USA/Sorgen vor falkenhafter Fed bremsen weiter
Acciones de firmas relacionadas a la marihuana escalan tras conocerse que DEA de EEUU reclasificaría el cannabis
Wall Street koerst af op vlakke opening
Amerikaanse futures wijzen op lagere opening Wall Street
More news

Managers and Directors - Canopy Growth Corp

Managers TitleAgeSince
David Klein CEO
 Chief Executive Officer 60 18-10-31
Judy Hong DFI
 Director of Finance/CFO 52 19-12-01
Tyler Burns IRC
 Investor Relations Contact - 15-12-31
Members of the board TitleAgeSince
David Klein CEO
 Chief Executive Officer 60 18-10-31
David Lazzarato CHM
 Chairman 69 20-03-30
Theresa Yanofsky BRD
 Director/Board Member 67 20-03-30
More insiders

Company Profile

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Sector
Pharmaceuticals
Calendar
2024-05-29 - Q4 2024 Earnings Release
More about the company

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.31% 6.19B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.99% 4.48B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+6.39% 3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-13.10% 3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-4.17% 2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+45.47% 1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-9.11% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-2.09% 1.64B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.50% 1.56B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. WEED Stock
  4. CGC Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW